William Blair Investment Management LLC Takes Position in HealthEquity, Inc. $HQY

William Blair Investment Management LLC acquired a new position in HealthEquity, Inc. (NASDAQ:HQY) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,773,227 shares of the company’s stock, valued at approximately $160,158,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Acumen Wealth Advisors LLC acquired a new stake in HealthEquity in the 4th quarter valued at approximately $27,000. Caitong International Asset Management Co. Ltd lifted its stake in HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after purchasing an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new position in shares of HealthEquity during the fourth quarter worth $28,000. Leonteq Securities AG boosted its position in shares of HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after buying an additional 235 shares during the period. Finally, Axiom Investment Management LLC acquired a new stake in shares of HealthEquity in the first quarter valued at $33,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling

In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total value of $298,490.00. Following the sale, the executive vice president owned 59,113 shares of the company’s stock, valued at $5,615,735. This trade represents a 5.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the transaction, the executive vice president owned 91,141 shares of the company’s stock, valued at $8,202,690. The trade was a 7.60% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 17,905 shares of company stock valued at $1,651,280 in the last three months. 1.60% of the stock is owned by corporate insiders.

HealthEquity Stock Performance

Shares of HQY stock opened at $105.41 on Friday. The company has a quick ratio of 3.44, a current ratio of 3.44 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $107.62. The stock has a market capitalization of $8.81 billion, a PE ratio of 39.48, a P/E/G ratio of 1.75 and a beta of 0.21. The firm has a 50 day moving average of $96.64 and a two-hundred day moving average of $87.20.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, research analysts predict that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on HQY shares. Barrington Research reiterated an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a report on Friday, May 22nd. Citizens Jmp raised their target price on HealthEquity from $110.00 to $111.00 and gave the company a “market outperform” rating in a report on Monday, June 1st. BTIG Research lifted their target price on HealthEquity from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Weiss Ratings upgraded shares of HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, June 5th. Finally, Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday. Eleven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $110.93.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.